ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRLnews2025-12-29T17:42:33+00:00December 29th, 2025|Endpoints News|
Nido Bio to wind down after underwhelming Phase 2 datanews2025-12-29T17:23:00+00:00December 29th, 2025|Endpoints News|
As gene editing tools multiply, the hunt for the final technology continuesnews2025-12-29T17:02:50+00:00December 29th, 2025|Endpoints News|
Turkey’s BOTAS seals Woodside LNG supply deal after busy dealmaking stretchnews2025-12-29T16:59:00+00:00December 29th, 2025|Independent Commodity Intelligence Services (ICIS)|
FBMC WEEKLY: Strong mid-week German wind output to pressure FBMC power spotnews2025-12-29T16:40:00+00:00December 29th, 2025|Independent Commodity Intelligence Services (ICIS)|
Ultragenyx, Mereo crash on late-stage bone disease failurenews2025-12-29T15:37:52+00:00December 29th, 2025|Endpoints News|
Genmab terminates Phase 3 lung cancer asset that BioNTech ditchednews2025-12-29T15:17:58+00:00December 29th, 2025|Endpoints News|
OUTLOOK ‘26: Europe rLDPE braces for volatility during uncertain 2026news2025-12-29T14:30:00+00:00December 29th, 2025|Independent Commodity Intelligence Services (ICIS)|
OUTLOOK ’26: Europe rPP insolvency risk remains highnews2025-12-29T14:00:00+00:00December 29th, 2025|Independent Commodity Intelligence Services (ICIS)|
OUTLOOK ’26: US PP facing tepid demand, abundant supplynews2025-12-29T14:00:00+00:00December 29th, 2025|Independent Commodity Intelligence Services (ICIS)|
